VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO WCGIC 2020 | Perioperative genotype-dosed FOLFIRINOX with margin-negative resection in gastroesophageal cancer

Daniel Catenacci, MD, University of Chicago, Chicago, IL, outlines pharmacogenomically dosed perioperative FOLFIRINOX in patients with locally advanced gastroesophageal adenocarcinoma. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter